Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 733,719 shares of HALO, which is worth approximately $43.4 Million. The most recent transaction as insider was on Feb 10, 2022, when has been sold 31,282 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 734K
10.05% 3M change
8.42% 12M change
Total Value Held $43.4 Million

Helen Torley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
31,282 Added 5.22%
568,442 Common Stock
Nov 08 2021
SELL
Open market or private sale
$2,001,000 $40.02 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Nov 08 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Oct 04 2021
SELL
Open market or private sale
$2,023,000 $40.46 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Oct 04 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Sep 07 2021
SELL
Open market or private sale
$2,132,000 $42.64 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Aug 10 2021
SELL
Open market or private sale
$2,157,000 $43.14 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Jul 06 2021
SELL
Open market or private sale
$2,298,500 $45.97 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Jul 06 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Jun 07 2021
SELL
Open market or private sale
$1,983,000 $39.66 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
May 11 2021
SELL
Open market or private sale
$2,177,000 $43.54 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Apr 05 2021
SELL
Open market or private sale
$2,127,500 $42.55 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Apr 05 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Mar 01 2021
SELL
Open market or private sale
$2,301,500 $46.03 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Feb 22 2021
SELL
Payment of exercise price or tax liability
$949,991 $48.69 p/Share
19,511 Reduced 3.5%
537,160 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
-
39,354 Added 6.6%
556,671 Common Stock
Feb 14 2021
SELL
Payment of exercise price or tax liability
$709,871 $49.84 p/Share
14,243 Reduced 2.68%
517,317 Common Stock
Feb 14 2021
BUY
Exercise of conversion of derivative security
-
28,729 Added 5.13%
531,560 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$810,349 $49.84 p/Share
16,259 Reduced 3.13%
502,831 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
32,795 Added 5.94%
519,090 Common Stock

Also insider at

DGX
QUEST DIAGNOSTICS INC Healthcare
HT

Helen Torley

PRESIDENT AND CEO
Secaucus, NJ

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO